blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2535072

EP2535072 - Subcutaneous infusion devices [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  14.04.2017
Database last updated on 02.09.2024
FormerExamination is in progress
Status updated on  09.01.2017
Most recent event   Tooltip14.04.2017Application deemed to be withdrawnpublished on 17.05.2017  [2017/20]
Applicant(s)For all designated states
C. R. BARD, INC.
730 Central Avenue
Murray Hill, NJ 07974 / US
[2012/51]
Inventor(s)01 / Barron, William R.
12124 So. 4250 West
Riverton, UT 84065 / US
02 / Burnside, Eddie K.
3107 Crestview Circle
Bountiful, UT 84010 / US
03 / Hamatake, Bret
434 Triple Crown Way
Grantsville, UT 84029 / US
04 / Powers, Kelly B.
8 N. Foxhill Road
North Salt Lake, UT 84054 / US
 [2012/51]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[N/P]
Former [2012/51]HOFFMANN EITLE
Patent- und Rechtsanwälte
Arabellastrasse 4
81925 München / DE
Application number, filing date12180240.907.06.2005
[2012/51]
Priority number, dateUS20040577658P07.06.2004         Original published format: US 577658 P
[2012/51]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2535072
Date:19.12.2012
Language:EN
[2012/51]
Type: A3 Search report 
No.:EP2535072
Date:27.03.2013
Language:EN
[2013/13]
Search report(s)(Supplementary) European search report - dispatched on:EP25.02.2013
ClassificationIPC:A61M5/178
[2012/51]
CPC:
A61M5/158 (EP,US); A61M25/005 (EP,US); A61M25/007 (EP,US);
A61M25/0637 (EP,US); A61M2005/1581 (EP,US); A61M25/0662 (EP,US)
Designated contracting statesDE,   ES,   FR,   GB,   IT [2012/51]
TitleGerman:Subkutane Infusionsvorrichtungen[2012/51]
English:Subcutaneous infusion devices[2012/51]
French:Dispositifs de perfusion sous-cutanée[2012/51]
Examination procedure13.08.2012Examination requested  [2012/51]
07.03.2013Amendment by applicant (claims and/or description)
02.05.2013Despatch of a communication from the examining division (Time limit: M06)
23.10.2013Reply to a communication from the examining division
27.07.2016Despatch of a communication from the examining division (Time limit: M04)
07.12.2016Application deemed to be withdrawn, date of legal effect  [2017/20]
10.01.2017Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2017/20]
Parent application(s)   TooltipEP05757206.7  / EP1768724
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20050757206) is  09.08.2010
Fees paidRenewal fee
13.08.2012Renewal fee patent year 03
13.08.2012Renewal fee patent year 04
13.08.2012Renewal fee patent year 05
13.08.2012Renewal fee patent year 06
13.08.2012Renewal fee patent year 07
13.08.2012Renewal fee patent year 08
27.08.2013Renewal fee patent year 09
12.06.2014Renewal fee patent year 10
10.06.2015Renewal fee patent year 11
Penalty fee
Additional fee for renewal fee
30.06.201309   M06   Fee paid on   27.08.2013
30.06.201612   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]WO8906553  (BAXTER INT [US]) [X] 1,3 * figure 5A * [Y] 2,4;
 [Y]US2002123724  (DOUGLAS JOEL S [US], et al) [Y] 5-8,13,14 * paragraphs [0041] - [0045] *;
 [XY]EP0810003  (TARGET THERAPEUTICS INC [US]) [X] 15 * column 7, line 41 - column 10, line 43 * * column 12, line 6 - column 16, line 21 * [Y] 2,5-8,13,14;
 [Y]US4834706  (BECK ANDREW J [US], et al) [Y] 4 * column 2, line 19 - column 6, line 9 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.